Literature DB >> 33654100

Complete biosynthesis of a sulfated chondroitin in Escherichia coli.

Abinaya Badri1, Asher Williams1, Adeola Awofiranye2, Payel Datta2, Ke Xia1, Wenqin He1, Keith Fraser2, Jonathan S Dordick1,2, Robert J Linhardt1,2,3, Mattheos A G Koffas4,5.   

Abstract

Sulfated glycosaminoglycans (GAGs) are a class of important biologics that are currently manufactured by extraction from animal tissues. Although such methods are unsustainable and prone to contamination, animal-free production methods have not emerged as competitive alternatives due to complexities in scale-up, requirement for multiple stages and cost of co-factors and purification. Here, we demonstrate the development of single microbial cell factories capable of complete, one-step biosynthesis of chondroitin sulfate (CS), a type of GAG. We engineer E. coli to produce all three required components for CS production-chondroitin, sulfate donor and sulfotransferase. In this way, we achieve intracellular CS production of ~27 μg/g dry-cell-weight with about 96% of the disaccharides sulfated. We further explore four different factors that can affect the sulfation levels of this microbial product. Overall, this is a demonstration of simple, one-step microbial production of a sulfated GAG and marks an important step in the animal-free production of these molecules.

Entities:  

Year:  2021        PMID: 33654100     DOI: 10.1038/s41467-021-21692-5

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  31 in total

1.  Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays.

Authors:  Eric L Shipp; Linda C Hsieh-Wilson
Journal:  Chem Biol       Date:  2007-02

2.  The FDA and safety--beyond the heparin crisis.

Authors:  Cato T Laurencin; Lakshmi Nair
Journal:  Nat Biotechnol       Date:  2008-06       Impact factor: 54.908

Review 3.  Medical application of glycosaminoglycans: a review.

Authors:  Alexander Köwitsch; Guoying Zhou; Thomas Groth
Journal:  J Tissue Eng Regen Med       Date:  2017-05-23       Impact factor: 3.963

Review 4.  The road to animal-free glycosaminoglycan production: current efforts and bottlenecks.

Authors:  Abinaya Badri; Asher Williams; Robert J Linhardt; Mattheos Ag Koffas
Journal:  Curr Opin Biotechnol       Date:  2018-01-04       Impact factor: 9.740

Review 5.  Chondroitin sulphate: a focus on osteoarthritis.

Authors:  Mamta Bishnoi; Ankit Jain; Pooja Hurkat; Sanjay K Jain
Journal:  Glycoconj J       Date:  2016-05-19       Impact factor: 2.916

Review 6.  Quality of different chondroitin sulfate preparations in relation to their therapeutic activity.

Authors:  Nicola Volpi
Journal:  J Pharm Pharmacol       Date:  2009-10       Impact factor: 3.765

7.  Contaminated heparin associated with adverse clinical events and activation of the contact system.

Authors:  Takashi Kei Kishimoto; Karthik Viswanathan; Tanmoy Ganguly; Subbiah Elankumaran; Sean Smith; Kevin Pelzer; Jonathan C Lansing; Nammalwar Sriranganathan; Ganlin Zhao; Zoya Galcheva-Gargova; Ali Al-Hakim; Gregory Scott Bailey; Blair Fraser; Sucharita Roy; Thomas Rogers-Cotrone; Lucinda Buhse; Mark Whary; James Fox; Moheb Nasr; Gerald J Dal Pan; Zachary Shriver; Robert S Langer; Ganesh Venkataraman; K Frank Austen; Janet Woodcock; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-04-23       Impact factor: 91.245

Review 8.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

Review 9.  Chondroitin sulfates and their binding molecules in the central nervous system.

Authors:  L Djerbal; H Lortat-Jacob; Jcf Kwok
Journal:  Glycoconj J       Date:  2017-01-18       Impact factor: 2.916

10.  Anti-cancer effect of dung beetle glycosaminoglycans on melanoma.

Authors:  Mi Young Ahn; Ban Ji Kim; Ha Jeong Kim; Jang Mi Jin; Hyung Joo Yoon; Jae Sam Hwang; Kun-Koo Park
Journal:  BMC Cancer       Date:  2019-01-05       Impact factor: 4.430

View more
  2 in total

Review 1.  Heterologous production of chondroitin.

Authors:  Márcia R Couto; Joana L Rodrigues; Lígia R Rodrigues
Journal:  Biotechnol Rep (Amst)       Date:  2022-02-10

2.  Escherichia coli BW25113 Competent Cells Prepared Using a Simple Chemical Method Have Unmatched Transformation and Cloning Efficiencies.

Authors:  Yuqing Yang; Qiaoli Yu; Min Wang; Rui Zhao; Huaiwei Liu; Luying Xun; Yongzhen Xia
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.